Planas, R; Martin, R; Sospedra, M (2014). Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life. Patient Related Outcome Measures, 5:25-33.
Jelcic, I; Aly, L; Binder, T M C; Jelcic, I; Bofill-Mas, S; Planas, R; Demina, V; Eiermann, T H; Weber, T; Girones, R; Sospedra, M; Martin, R (2013). T cell epitope mapping of JC polyoma virus-encoded proteome reveals reduced T cell responses in HLA-DRB1*04:01+ donors. Journal of Virology, 87(6):3393-3408.
Planas, R; Jelčić, I; Schippling, S; Martin, R; Sospedra, M (2012). Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis. European Journal of Immunology, 42(3):790-798.
Yousef, S; Planas, R; Chakroun, K; Hoffmeister-Ullerich, S; Binder, T M C; Eiermann, T H; Martin, R; Sospedra, M (2012). TCR bias and HLA cross-restriction are strategies of human brain-infiltrating JC virus-specific CD4+ T cells during viral infection. Journal of Immunology, 189(7):3618-3630.